Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior Therapy | 1 | 2020 | 29 | 0.650 |
Why?
|
| Weight Loss | 1 | 2020 | 81 | 0.630 |
Why?
|
| Hepatitis C | 2 | 2020 | 40 | 0.320 |
Why?
|
| Esotropia | 1 | 2007 | 6 | 0.280 |
Why?
|
| Mass Screening | 2 | 2020 | 153 | 0.270 |
Why?
|
| Indians, North American | 3 | 2019 | 517 | 0.200 |
Why?
|
| Disease Eradication | 1 | 2020 | 9 | 0.180 |
Why?
|
| Patient Care Management | 1 | 2020 | 10 | 0.170 |
Why?
|
| Overweight | 1 | 2020 | 111 | 0.150 |
Why?
|
| Health Personnel | 1 | 2019 | 95 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2020 | 436 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 118 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 166 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 296 | 0.130 |
Why?
|
| United States Indian Health Service | 1 | 2016 | 14 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 32 | 0.120 |
Why?
|
| Incidence | 3 | 2020 | 562 | 0.120 |
Why?
|
| Male | 6 | 2020 | 13511 | 0.120 |
Why?
|
| Female | 7 | 2020 | 15192 | 0.120 |
Why?
|
| Adult | 4 | 2020 | 7765 | 0.110 |
Why?
|
| Obesity | 1 | 2020 | 668 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2007 | 141 | 0.110 |
Why?
|
| Middle Aged | 3 | 2020 | 7164 | 0.100 |
Why?
|
| Humans | 8 | 2020 | 28168 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2014 | 890 | 0.090 |
Why?
|
| Uterine Inversion | 1 | 2009 | 1 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2020 | 167 | 0.080 |
Why?
|
| Infant | 2 | 2014 | 1014 | 0.080 |
Why?
|
| United States | 3 | 2020 | 2151 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 24 | 0.070 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2007 | 15 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2020 | 889 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 465 | 0.060 |
Why?
|
| Pregnancy | 2 | 2007 | 1191 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 818 | 0.060 |
Why?
|
| Hypertension | 1 | 2007 | 309 | 0.060 |
Why?
|
| Health Status Disparities | 2 | 2016 | 64 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 367 | 0.050 |
Why?
|
| Risk Factors | 1 | 2007 | 2087 | 0.050 |
Why?
|
| Young Adult | 3 | 2016 | 2738 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 9 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2001 | 32 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2007 | 2558 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2019 | 16 | 0.040 |
Why?
|
| Health Services, Indigenous | 1 | 2019 | 16 | 0.040 |
Why?
|
| Community Health Services | 1 | 2019 | 33 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2019 | 115 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2016 | 7 | 0.030 |
Why?
|
| Organizational Policy | 1 | 2016 | 19 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2016 | 48 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2016 | 68 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2016 | 112 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 5417 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2014 | 86 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 478 | 0.020 |
Why?
|
| Oklahoma | 1 | 2014 | 1005 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1149 | 0.020 |
Why?
|
| Afghanistan | 1 | 2009 | 3 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2021 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2253 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3128 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2001 | 6 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2001 | 15 | 0.010 |
Why?
|
| Birth Weight | 1 | 2001 | 63 | 0.010 |
Why?
|
| Gestational Age | 1 | 2001 | 146 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2001 | 724 | 0.010 |
Why?
|